Showing results (801-810 of 4,513) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|June 26, 2019
Management of distal ureter and bladder cuff at the time of nephroureterectomy: surgical techniques and predictors of outcomeKyrollis Attalla, Shyam Patnaik, Ted Vellos, et al.
Future Oncology (London, England)|October 10, 2019
Healthcare resource utilization and costs of adverse events among patients with metastatic urothelial cancer in USAPetros Grivas, Maral DerSarkissian, Rahul Shenolikar, et al.
Future Oncology (London, England)|April 26, 2021
Evolving role of entrectinib in treatment of NTRK-positive tumorsNeal Chawla, Nam Q Bui, Mahesh Seetharam
Future Oncology (London, England)|March 30, 2021
Immune-related adverse events with PD-1 versus PD-L1 inhibitors: a meta-analysis of 8730 patients from clinical trialsGuru P Sonpavde, Petros Grivas, Yushun Lin, et al.
Future Oncology (London, England)|March 12, 2015
Assessment of early response to imatinib 800 mg after 400 mg progression by ¹⁸F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumorsMatías Chacón, Martín Eleta, Adriel Rodríguez Espindola, et al.
Future Oncology (London, England)|August 14, 2020
POLARIS: a prospective, multicenter, noninterventional study assessing palbociclib in hormone receptor-positive advanced breast cancerDebasish Tripathy, Joanne L Blum, Gabrielle B Rocque, et al.
Future Oncology (London, England)|May 3, 2023
Medicare characteristics, treatment, cost and survival in triple class exposed relapsed or refractory multiple myelomaPatrick Hlavacek, Alex Schepart, Alison R Silverstein, et al.
Future Oncology (London, England)|March 26, 2021
Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myelomaRoman Hájek, Jiří Minařík, Jan Straub, et al.
Future Oncology (London, England)|August 18, 2020
Cancer-associated fibroblasts induce epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer via CXCL12/CXCR4 axisFang Zhang, Jian-Ying Cui, Hai-Feng Gao, et al.
Future Oncology (London, England)|August 21, 2020
The combination of histone deacetylase inhibitors and radiotherapy: a promising novel approach for cancer treatmentEkta Shirbhate, Preeti Patel, Vijay K Patel, et al.
Pageof 452